Literature DB >> 21636860

G-CSF receptor activation of the Src kinase Lyn is mediated by Gab2 recruitment of the Shp2 phosphatase.

Muneyoshi Futami1, Quan-Sheng Zhu, Zakary L Whichard, Ling Xia, Yuehai Ke, Benjamin G Neel, Gen-Sheng Feng, Seth J Corey.   

Abstract

Src activation involves the coordinated regulation of positive and negative tyrosine phosphorylation sites. The mechanism whereby receptor tyrosine kinases, cytokine receptors, and integrins activate Src is not known. Here, we demonstrate that granulocyte colony-stimulating factor (G-CSF) activates Lyn, the predominant Src kinase in myeloid cells, through Gab2-mediated recruitment of Shp2. After G-CSF stimulation, Lyn dynamically associates with Gab2 in a spatiotemporal manner. The dephosphorylation of phospho-Lyn Tyr507 was abrogated in Shp2-deficient cells transfected with the G-CSF receptor but intact in cells expressing phosphatase-defective Shp2. Auto-phosphorylation of Lyn Tyr396 was impaired in cells treated with Gab2 siRNA. The constitutively activated Shp2E76A directed the dephosphorylation of phospho-Lyn Tyr507 in vitro. Tyr507 did not undergo dephosphorylation in G-CSF-stimulated cells expressing a mutant Gab2 unable to bind Shp2. We propose that Gab2 forms a complex with Lyn and after G-CSF stimulation, Gab2 recruits Shp2, which dephosphorylates phospho-Lyn Tyr507, leading to Lyn activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21636860      PMCID: PMC3148159          DOI: 10.1182/blood-2009-12-261636

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand.

Authors:  F Liu; J Poursine-Laurent; D C Link
Journal:  Blood       Date:  1997-10-01       Impact factor: 22.113

2.  Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations.

Authors:  M Golam Mohi; Ifor R Williams; Charles R Dearolf; Gordon Chan; Jeffery L Kutok; Sarah Cohen; Kelly Morgan; Christina Boulton; Hirokazu Shigematsu; Heike Keilhack; Koichi Akashi; D Gary Gilliland; Benjamin G Neel
Journal:  Cancer Cell       Date:  2005-02       Impact factor: 31.743

3.  Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation.

Authors:  H Gu; J C Pratt; S J Burakoff; B G Neel
Journal:  Mol Cell       Date:  1998-12       Impact factor: 17.970

Review 4.  Src-related protein tyrosine kinases in hematopoiesis.

Authors:  S J Corey; S M Anderson
Journal:  Blood       Date:  1999-01-01       Impact factor: 22.113

5.  Gab2, a new pleckstrin homology domain-containing adapter protein, acts to uncouple signaling from ERK kinase to Elk-1.

Authors:  C Zhao; D H Yu; R Shen; G S Feng
Journal:  J Biol Chem       Date:  1999-07-09       Impact factor: 5.157

6.  Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells.

Authors:  Suzanne Schubbert; Kenneth Lieuw; Sara L Rowe; Connie M Lee; Xiaxin Li; Mignon L Loh; D Wade Clapp; Kevin M Shannon
Journal:  Blood       Date:  2005-03-10       Impact factor: 22.113

Review 7.  C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.

Authors:  Yuh-Ping Chong; Terrence D Mulhern; Heung-Chin Cheng
Journal:  Growth Factors       Date:  2005-09       Impact factor: 2.511

8.  Requirement of Src kinase Lyn for induction of DNA synthesis by granulocyte colony-stimulating factor.

Authors:  S J Corey; P M Dombrosky-Ferlan; S Zuo; E Krohn; A D Donnenberg; P Zorich; G Romero; M Takata; T Kurosaki
Journal:  J Biol Chem       Date:  1998-02-06       Impact factor: 5.157

9.  The Src-like tyrosine kinase Hck is activated by granulocyte colony-stimulating factor (G-CSF) and docks to the activated G-CSF receptor.

Authors:  A C Ward; J L Monkhouse; X F Csar; I P Touw; P A Bello
Journal:  Biochem Biophys Res Commun       Date:  1998-10-09       Impact factor: 3.575

10.  Biased suppression of hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant cells.

Authors:  C K Qu; W M Yu; B Azzarelli; S Cooper; H E Broxmeyer; G S Feng
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

View more
  22 in total

1.  Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition.

Authors:  H M Mehta; M Futami; T Glaubach; D W Lee; J R Andolina; Q Yang; Z Whichard; M Quinn; H F Lu; W M Kao; B Przychodzen; C A Sarkar; A Minella; J P Maciejewski; S J Corey
Journal:  Leukemia       Date:  2013-10-30       Impact factor: 11.528

2.  Dynamins 2 and 3 control the migration of human megakaryocytes by regulating CXCR4 surface expression and ITGB1 activity.

Authors:  Praveen K Suraneni; Seth J Corey; Michael J Hession; Rameez Ishaq; Arinola Awomolo; Shirin Hasan; Chirag Shah; Hui Liu; Amittha Wickrema; Najet Debili; John D Crispino; Elizabeth A Eklund; Yolande Chen
Journal:  Blood Adv       Date:  2018-12-11

3.  Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization.

Authors:  Julia E Maxson; Samuel B Luty; Jason D MacManiman; Melissa L Abel; Brian J Druker; Jeffrey W Tyner
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

Review 4.  Severe congenital neutropenias.

Authors:  Julia Skokowa; David C Dale; Ivo P Touw; Cornelia Zeidler; Karl Welte
Journal:  Nat Rev Dis Primers       Date:  2017-06-08       Impact factor: 52.329

5.  CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML.

Authors:  Julia E Maxson; Rhonda E Ries; Yi-Cheng Wang; Robert B Gerbing; E Anders Kolb; Sarah L Thompson; Jaime M Guidry Auvil; Marco A Marra; Yussanne Ma; Zusheng Zong; Andrew J Mungall; Richard Moore; William Long; Patee Gesuwan; Tanja M Davidsen; Leandro C Hermida; Seamus B Hughes; Jason E Farrar; Jerald P Radich; Malcolm A Smith; Daniela S Gerhard; Alan S Gamis; Todd A Alonzo; Soheil Meshinchi
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113

Review 6.  Systems approach to phagocyte production and activation: neutrophils and monocytes.

Authors:  Hrishikesh M Mehta; Taly Glaubach; Seth Joel Corey
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

7.  Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors.

Authors:  Vindhya Udhane; Cristina Maranto; David T Hoang; Lei Gu; Andrew Erickson; Savita Devi; Pooja G Talati; Anjishnu Banerjee; Kenneth A Iczkowski; Kenneth Jacobsohn; William A See; Tuomas Mirtti; Deepak Kilari; Marja T Nevalainen
Journal:  Mol Cancer Ther       Date:  2019-09-23       Impact factor: 6.261

Review 8.  G-CSF and GM-CSF in Neutropenia.

Authors:  Hrishikesh M Mehta; Michael Malandra; Seth J Corey
Journal:  J Immunol       Date:  2015-08-15       Impact factor: 5.422

Review 9.  C/EBPα in normal and malignant myelopoiesis.

Authors:  Alan D Friedman
Journal:  Int J Hematol       Date:  2015-03-10       Impact factor: 2.490

Review 10.  Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.

Authors:  Katerina Zoi; Nicholas C P Cross
Journal:  Int J Hematol       Date:  2014-09-12       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.